We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Insights into Blood Diseases from Worms and Mice

By Biotechdaily staff writers
Posted on 23 May 2002
Results from genetic studies on microscopic worms extrapolated to a mouse model have revealed comparable genes that control early blood-cell development.

"We think we have found a way of efficiently studying how early blood-cell development is controlled and how gene defects in this process might lead to the development of blood diseases, including cancer,” said Dr. Scott Cameron, an assistant professor of pediatrics and molecular biology at the University of Texas Southwestern Medical Center (Dallas, USA).

The research was reported in the February 1, 2002, issue of Genes & Development (mouse study) and in the April 1, 2002, issue of Development (worm study). Dr. Cameron and colleagues from Harvard Medical School (Boston, MA, USA; www.med.harvard.edu) found that the pag-3 gene determines the fate of embryonic nerve cells in the microscopic worm Caenorhabditis elegans, a common soil nematode that was one of the first animals to have its genome sequenced. Worms with a mutation on the pag-3 gene did not develop the neuron cells that control forward and backward mobility.

"In the gene-deprived mice, I found a defect in blood formation exactly consistent with what was predicted by the worm work,” said Dr. Cameron. The mouse study revealed that when the Gfi-1b gene is muted in mice, their blood-stem cells fail to form red cells and platelets, causing mice embryos to die 11-12 days after fertilization. Related research has shown that knocking out the sister Gfi-1 gene prevents development of certain white blood cells, resulting in the mice dying shortly after birth. The blood-cell genetic defects in the mice were consistent with the defect identified in embryonic nerve cells in C elegans.

Dr. Cameron hopes to find comparable links to cancer tumors in humans, though he cautions that gene numbers, roles, mutations and other variants contrast sharply between the mouse and human genomes and raise major challenges for human-disease research. "But I know that, overall, I'm in the right genetic neighborhood,” he said.





Related Links:
Southwestern Medical Center
Harvard Medical School

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Urine Chemistry Control
Dropper Urine Chemistry Control

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
23 May 2002  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
23 May 2002  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
23 May 2002  |   BioResearch